Liberum Capital Reiterates Buy Rating for Centrica (CNA)
Centrica (LON:CNA)‘s stock had its “buy” rating reaffirmed by equities researchers at Liberum Capital in a research report issued on Wednesday, StockRatingsNetwork reports. They currently have a GBX 440 ($7.12) price target on the stock. Liberum Capital’s price objective would suggest a potential upside of 24.01% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Macquarie reiterated a “neutral” rating on shares of Centrica in a research note to investors on Friday, October 25th. They now have a GBX 360 ($5.82) price target on the stock. Separately, analysts at Raymond James reiterated an “underperform” rating on shares of Centrica in a research note to investors on Friday, October 18th. They now have a GBX 347 ($5.61) price target on the stock. Finally, analysts at Credit Suisse reiterated an “underperform” rating on shares of Centrica in a research note to investors on Friday, October 18th. They now have a GBX 320 ($5.18) price target on the stock. Five analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Centrica currently has a consensus rating of “Hold” and an average price target of GBX 384.72 ($6.22).
Shares of Centrica (LON:CNA) opened at 354.80 on Wednesday. Centrica has a one year low of GBX 308.80 and a one year high of GBX 403.308. The stock’s 50-day moving average is GBX 370.8 and its 200-day moving average is GBX 377.8. The company’s market cap is £18.382 billion.
Centrica plc is an integrated energy company. The Company operates in four segments: Downstream UK, Upstream UK, Storage UK and North America.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.